Glioblastoma (GBM) is the most common and aggressive primary malignant brain tumor and
is characterized by high mortality and morbidity rates and unpredictable clinical behavior …

Exosomes are the main actors of intercellular communications and have gained great
interest in the new cell-free regenerative medicine. These nanoparticles are secreted by …

The telomeric repeat‐binding factor 2 (TRF2) is a telomere‐capping protein that plays a key
role in the maintenance of telomere structure and function. It is highly expressed in different …

Background It has been a long-held consensus that immune reactions primarily mediate the
pathology of chronic obstructive pulmonary disease (COPD), and that exosomes may …

Glioblastoma (GBM) is the most common malignant brain tumor. Available treatments have
limited success because most patients develop chemoresistance. Alternative strategies are …

Simple Summary Despite advancements in healthcare and research, the occurrence of
gliomas, a type of brain tumor, continues to rise. Emerging evidence has proven that …

Gliomas, particularly glioblastoma (GBM), represent the most prevalent and aggressive
tumors of the central nervous system (CNS). Despite recent treatment advancements, patient …

Glioblastoma (GBM) is a primary CNS tumor that is highly lethal in adults and has limited
treatment options. Despite advancements in understanding the GBM biology, the standard …

The proliferation, metastasis and therapy response of tumour cells are tightly regulated by
interaction among various signalling networks. The microRNAs (miRNAs) can bind to 3 …

Background Glioblastoma (GBM) is the most frequent type of primary brain cancer, having a
median survival of only 15 months. The current standard of care includes a combination of …